Albert Quiery

656 total citations
13 papers, 414 citations indexed

About

Albert Quiery is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Albert Quiery has authored 13 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Albert Quiery's work include Mast cells and histamine (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Bone health and treatments (2 papers). Albert Quiery is often cited by papers focused on Mast cells and histamine (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Bone health and treatments (2 papers). Albert Quiery collaborates with scholars based in United States, United Kingdom and Germany. Albert Quiery's co-authors include Kai Zhang, Conrad Schuerch, Jeffrey W. Prichard, Moshe Talpaz, Ryan A. Wilcox, Mark Kaminski, Asra Ahmed, Paula Bockenstedt, Erica Campagnaro and Suman L. Sood and has published in prestigious journals such as Nature Medicine, Blood and Archives of Pathology & Laboratory Medicine.

In The Last Decade

Albert Quiery

12 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Quiery United States	7	203	162	148	118	78	13	414
Joseena Iype Switzerland	9	154 0.8×	59 0.4×	113 0.8×	43 0.4×	32 0.4×	12	379
Hajime Yasuda Japan	11	66 0.3×	93 0.6×	74 0.5×	111 0.9×	19 0.2×	55	366
László Gopcsa Hungary	13	100 0.5×	132 0.8×	36 0.2×	92 0.8×	14 0.2×	44	339
MQ Lacy United States	9	68 0.3×	156 1.0×	37 0.3×	65 0.6×	22 0.3×	12	313
Anna Maria Frustaci Italy	15	62 0.3×	181 1.1×	64 0.4×	111 0.9×	15 0.2×	63	515
Ana Sureda Spain	10	127 0.6×	328 2.0×	40 0.3×	126 1.1×	11 0.1×	15	544
Andreza Alice Feitosa Ribeiro Brazil	12	112 0.6×	251 1.5×	22 0.1×	117 1.0×	19 0.2×	44	456
Maoquan Qin China	10	59 0.3×	137 0.8×	24 0.2×	90 0.8×	65 0.8×	45	341
Angela R. Manser Germany	11	387 1.9×	149 0.9×	20 0.1×	129 1.1×	18 0.2×	11	527
Lien De Somer Belgium	12	288 1.4×	199 1.2×	38 0.3×	63 0.5×	10 0.1×	34	509

Countries citing papers authored by Albert Quiery

Since Specialization

Citations

This map shows the geographic impact of Albert Quiery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Quiery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Quiery more than expected).

Fields of papers citing papers by Albert Quiery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Quiery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Quiery. The network helps show where Albert Quiery may publish in the future.

Co-authorship network of co-authors of Albert Quiery

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Quiery. A scholar is included among the top collaborators of Albert Quiery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Quiery. Albert Quiery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

DeAngelo, Daniel J., Deepti Radia, Tracy I. George, et al.. (2022). An Updated Analysis on Safety and Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis from the Explorer Clinical Study: Long-Term Efficacy and Safety. Blood. 140(Supplement 1). 3932–3934.

DeAngelo, Daniel J., Deepti Radia, Tracy I. George, et al.. (2021). Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial. Nature Medicine. 27(12). 2183–2191. 88 indexed citations

Gotlib, Jason, Deepti Radia, Tracy I. George, et al.. (2020). Pure Pathologic Response Is Associated with Improved Overall Survival in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib in the Phase I EXPLORER Study. Blood. 136(Supplement 1). 37–38. 6 indexed citations

Ahmed, Asra, Samuel A. Merrill, Paula Bockenstedt, et al.. (2019). Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. The Lancet Haematology. 6(12). e630–e637. 191 indexed citations

Radia, Deepti, Jason Gotlib, Mark W. Drummond, et al.. (2019). S830 AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM). HemaSphere. 3(S1). 368–368. 7 indexed citations

Merrill, Samuel A., Paula Bockenstedt, Erica Campagnaro, et al.. (2018). Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Center Study. Blood. 132(Supplement 1). 1119–1119. 1 indexed citations

Drummond, Mark W., Daniel J. DeAngelo, Michael W. Deininger, et al.. (2016). Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM). Blood. 128(22). 477–477. 10 indexed citations

Berenson, James R., Ori Yellin, Albert Quiery, et al.. (2011). A Retrospective Study to Evaluate the Work-up and Follow-up of Patients With Monoclonal Gammopathy of Undetermined Significance. Clinical Lymphoma Myeloma & Leukemia. 11(4). 336–341. 2 indexed citations

Zhang, Ping L., et al.. (2007). Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.. PubMed. 37(1). 34–8. 4 indexed citations

10.

Lin, Fan, Kai Zhang, Albert Quiery, Jeffrey W. Prichard, & Conrad Schuerch. (2004). Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature.. Archives of Pathology & Laboratory Medicine. 128(5). 581–4. 47 indexed citations

11.

Lin, Fan, Kai Zhang, Albert Quiery, Jeffrey W. Prichard, & Conrad Schuerch. (2004). Plasmablastic Lymphoma of the Cervical Lymph Nodes in a Human Immunodeficiency Virus–Negative Patient: A Case Report and Review of the Literature. Archives of Pathology & Laboratory Medicine. 128(5). 581–584. 43 indexed citations

12.

Stanley, Wayne S., Sandra Burkett, Albert Quiery, et al.. (1997). Constitutional inversion of chromosome 7 and hematologic cancers. Cancer Genetics and Cytogenetics. 96(1). 46–49. 12 indexed citations

13.

Quiery, Albert, et al.. (1991). Chloroquine-ResistantPlasmodium falciparum. Laboratory Medicine. 22(3). 167–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact